Abstracts » Business, international

Nycomed Amersham sells unit

Article Abstract:

Nycomed Amersham PLC announced that it is selling off 70% of its Nycomed Pharma pharmaceuticals subsidiary to Nordic Capital. Nycomed Amersham is selling the subsidiary for 340 million pound sterling ($553.7 million). Nycomed Pharma will be controlled and run by Nordic Capital, a private equity firm based in Oslo, Norway. The remaining 30% share will be held by Nycomed Amersham after it invests 21 million pound sterling into the firm.

Comment:

Nycomed Amersham to sell 70% of Nycomed Pharma to Nordic Capital for 340 mil pound sterling ($553.7 mil)

Asset sales & divestitures, Acquisitions & mergers, Foreign operations, Norway, Inorganic Chemicals, Other Basic Inorganic Chemical Manufacturing, Mergers, acquisitions and divestments, Chemical industry, Inorganic compounds, Nordic Capital, Nycomed Pharma

---

Nycomed Amersham posts 12% rise in pretax profit

Article Abstract:

Nycomed Amersham PLC announced that its pretax profits for 1998 increased 12% to 222.8 million pound sterling ($358 million). In 1997, the company posted 198.6 million pound sterling in pretax profits. The 1998 figures were higher than what analysts had predicted. Nycomed also posted a total of 32 million pound sterling in cost savings from the merger of Amersham, Nycomed, and Pharmacia Biotech.

Comment:

Pretax profits for 1998 increase 12% to 222.8 million pound sterling ($358 million)

Sales, profits & dividends, Biochemistry, Research and Development in the Physical, Engineering, and Life Sciences, Biotechnology industry, Biotechnology industries, Finance, Abstract

---

Nycomed Amersham wins key ruling on genetic code

Article Abstract:

The article discusses the key ruling Nycomed Amersham PLC has won at the expense of Applera Corp.'s Applied Biosytems Group. At stake is a patent for colored dyes used to label the four letters--A, T, C and G--that spell out the DNA sequence.

Biological Product (except Diagnostic) Manufacturing, Drugs, Biological Products, Patents & copyrights, Pharmaceutical industry, Biological products industry, Intellectual property, GE Healthcare, Applied Biosystems Ltd.

Some parts © 2012 Advameg, Inc.